The effect of SH on renal progression was attenuated in the participants who had renal insufficiency or used insulin, owing to the possibility that the group of patients with these conditions may have included more patients with high-risk factors for progression of renal function, including longer diabetes duration, older age, comorbidities, or renal insufficiency itself. Here, INS is linked to diabetes mellitus.